Paroxysmal nocturnal hemoglobinuria and eculizumab

被引：55
|
作者：
Luzzatto, Lucio [1 ]
Risitano, Antonio Maria [2 ]
Notaro, Rosario [1 ]
机构：
[1] Azienda Osped Univ Careggi, Ist Toscano Tumori, Core Res Lab, Florence, Italy
[2] Univ Naples Federico 2, Div Ematol, Dipartimento Biochim & Biotecnol Med, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 04期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; RED-BLOOD-CELLS; NATURAL-HISTORY; THROMBOSIS; DISEASE; MECHANISM; PNH;
D O I：
10.3324/haematol.2009.017848
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：523 / 526
页数：4
相关论文
共 50 条
  • [41] Paroxysmal Nocturnal Hemoglobinuria -- Hemolysis before and after Eculizumab.
    Risitano, Antonio M.
    Notaro, Rosario
    Luzzatto, Lucio
    Hill, Anita
    Kelly, Richard
    Hillmen, Peter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2270 - 2273
  • [42] Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
    Ilic, Jovanka
    Pujic, Borislava
    Jakovljevic, Branislava
    Sekulic, Borivoj
    Agic, Danijela
    El Farra, Amir
    Micanovic, Branimir
    Vejnovic, Tihomir
    Urosevic, Ivana
    Savic, Aleksandar
    [J]. CLINICAL CASE REPORTS, 2024, 12 (05):
  • [43] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [44] Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience
    de Guibert, Sophie
    de Latour, Regis Peffault
    Varoqueaux, Nathalie
    Labussiere, Helene
    Rio, Bernard
    Jaulmes, Dominique
    Eveillard, Jean-Richard
    Dulucq, Stephanie
    Stoppa, Anne-Marie
    Bouscary, Didier
    Girodon, Francois
    Bonnotte, Bernard
    Laskri, Djamila
    Socie, Gerard
    Lamy, Thierry
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (09): : 1276 - 1283
  • [45] Extravascular hemolytic attack after eculizumab therapy for paroxysmal nocturnal hemoglobinuria
    Tomita, Akihiro
    Shirasugi, Yukari
    Ito, Takahiko
    Tsurumi, Hisashi
    Naoe, Tomoki
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (07) : 1139 - 1141
  • [46] Eculizumab Treatment Improves Outcomes of Pregnancy in Patients with Paroxysmal Nocturnal Hemoglobinuria
    Kelly, Richard J.
    Hoechsmann, Britta
    Kulasekararaj, Austin
    de Guibert, Sophie
    Roeth, Alexander
    Weitz, Ilene C.
    Armstrong, Elina
    Hill, Anita
    Risitano, Antonio M.
    Patriquin, Christopher J.
    Terriou, Louis
    Muus, Petra
    Turner, Michelle P.
    Schrezenmeier, Hubert
    Szer, Jeffrey
    de latour, Regis Peffault
    [J]. BLOOD, 2014, 124 (21)
  • [47] Ten Years of Clinical Experience With Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
    de Fontbrune, Flore Sicre
    de latour, Regis Peffault
    [J]. SEMINARS IN HEMATOLOGY, 2018, 55 (03) : 124 - 129
  • [48] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    [J]. Nature Biotechnology, 2007, 25 : 1256 - 1264
  • [49] Eculizumab treatment improved renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria
    Seiko Iki
    Kazuyuki Ohgi
    Kenshi Suzuki
    [J]. International Journal of Hematology, 2017, 105 : 231 - 232
  • [50] Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, P
    Hall, C
    Marsh, JCW
    Elebute, M
    Bombara, MP
    Petro, BE
    Cullen, MJ
    Richards, SJ
    Rollins, SA
    Mojcik, CF
    Rother, RP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06): : 552 - 559
12345